4 ms·

There are literally 100s of thousands, if not millions of healthcare workers, why could they only perform this study on 48 of them?

• melling 5y ago
  I imagine it’s quite expensive to test 100,000 people. Isn’t the idea to simply fine statistically significant results? That’s all you’re going to get funding for?
  • alexk307 5y ago
    The world spent trillions of dollars fighting this pandemic, and is still hemorrhaging cash all over the planet. A few more blood tests for such an important claim would have been very much worth it. Not saying test all 100k, but 48? I guess that's statistically significant, but it seems like a hard task to find a cohort of 48 people that can statistically represent all the US health care workers.
    • s1artibartfast 5y ago
      Lack of leadership, organization, manpower, and intelligence. This is the same reason that we are two years in the pandemic and still haven't evaluated repurposing many safe medications to reduce mortality. It will be very sad if we could have reduced global deaths by 25% using drugs that were sitting on the shelf the whole time.
      • nradov 5y ago
        The NIH is sponsoring the ACTIV trials of repurposed medications. Could have been started sooner, though. https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials https://www.nih.gov/research-training/medical-research-initi...
        • s1artibartfast 5y ago
          Yeah, my point exactly. It readouts out at end of this year, ~3 years in. There are no physical limitations preventing this from being done in months. It is the human factors that fuck it up
    • deleted 5y ago
      [deleted]